Unity Biotechnology Stock (NASDAQ: UBX)
|Day Range0.39 - 0.42||52 Wk Range0.39 - 1.91||Open / Close0.4 / 0.4||Float / Outstanding138.4M / 140.2M|
|Vol / Avg.910.3K / 3.8M||Mkt Cap55.7M||P/E-||50d Avg. Price0.65|
|Div / Yield-||Payout Ratio-||Total Float138.4M||EPS-0.19|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Unity Biotechnology (NASDAQ: UBX) through any online brokerage.
The latest price target for Unity Biotechnology (NASDAQ: UBX) was reported by Mizuho on Tuesday, August 16, 2022. The analyst firm set a price target for 8.00 expecting UBX to rise to within 12 months (a possible 1914.61% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Unity Biotechnology (NASDAQ: UBX) is $0.3971 last updated September 26, 2022, 8:00 PM UTC.
There are no upcoming dividends for Unity Biotechnology.
Unity Biotechnology’s Q3 earnings are confirmed for Wednesday, November 9, 2022.
There is no upcoming split for Unity Biotechnology.
Unity Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.